SCHEMBL8303345

SCHEMBL8303345

CCCCN1CC2CN(S(=O)(=O)c3ccc(-n4ccnc4)cc3)CC(C1)C2(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.43
CYP3A4 P08684 3/20 0.43
CYP19A1 P11511 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
CHRNA7 P36544 1/20 0.41
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MCHR1 Q99705 1/20 0.37
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
TP53 P04637 1/20 0.36
PDE2A O00408 1/20 0.35
BAZ2B Q9UIF8 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8303218 0.79 MEN1 (0.39) CYP19A1LMNAHTTALDH1A1POLB
SCHEMBL8873628 0.79 L3MBTL1 (0.47) CYP3A4CYP2C19ALDH1A1HTR2AHTR2C
SCHEMBL8304050 0.76 HRH2 (0.47) CYP3A4CYP19A1SMN1; SMN2ALDH1A1USP2
SCHEMBL8303793 0.76 GAA (0.49) CYP2D6CYP2C19LMNAHTTSMN1; SMN2
Hydrochloric Acid SCHEMBL8306472 0.75 HRH2 (0.46) CYP3A4CYP19A1SMN1; SMN2ALDH1A1USP2
SCHEMBL9520302 0.74 RAB9A (0.45) SMN1; SMN2TSHR
Hydrochloric Acid SCHEMBL9522648 0.73 RAB9A (0.47) SMN1; SMN2TSHR
SCHEMBL6324442 0.69 CHRNA7 (0.47) CYP2D6CYP3A4CYP19A1CHRNA7LMNA
SCHEMBL10673408 0.67 GLB1 (0.52)
SCHEMBL27774380 0.67 POLB (0.56) CYP2D6CYP3A4CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0665228-B1 Pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes SOLVAY PHARM GMBH (DE) 1999-07-14 EP disclosed
US-5635511-A ACID ADDITION SALT DERIVATIVES; ANTIARRHYTHMIA AGENTS; ACTIVE SUPPRESSION OF EXTRASYSTOLES, VENTRICULAR FLUTTERS AND FIBRILLATIONS KALI-CHEMIE PHARMA GMBH (DE) 1997-06-03 US disclosed
US-5576327-A Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds KALI-CHEMIE PHARMA GMBH (DE) 1996-11-19 US disclosed
EP-0665228-A1 Pharmaceutical compositions containing 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes Kali-Chemie Pharma GmbH (DE) 1995-08-02 EP disclosed